臨床薬理学 | |||||||
Clinical Pharmacology and Therapeutics | |||||||
整理番号 | 論文の種類 | 著者名 | 論文タイトル | 誌名、書名等 | 巻号ページ | 年 | doi |
2257001 | 原著 | Doi T. Hojo H. Ohba S. Obayashi K. Endo M. Ishizaki T. Katoh A. Kouji H. | Involvement of activator protein-1 family members in β-catenin and p300 association on the genome of PANC-1 cells | Heliyon | 2022, 8, e08890 | 2022 | |
2257002 | 原著 | Kami D. Ishizaki T. Taya T. Katoh A. Kouji H. Gojo S. | A novel mRNA decay inhibitor abolishes pathophysiological cellular transition | Cell Death Discovery | 2022, 278 1-9 | 2022 | 10.1038/s41420-022-01076-4 |
2257003 | 症例報告 | Hayashi K, Ito T, Hachiya K, Ichihashi T, Sakurai Y, Murakami Y, Kamiya S, Saito J, Asano M, Seo Y. | Sudden Cardiac Arrest Due to Spontaneous Coronary Artery Rupture - A Case Report with a Diagnostic Challenge - | Internal Medicne | 2022 Volume 61 Issue 22 Pages 3369-3372 | 2022 | 10.2169/internalmedicine.9369-22 |
2257004 | 原著 | Nozawa A, Fujino A, Yuzuriha S, Suenobu S, Kato A, Shimizu F, Aramaki-Hattori N, Kuniyeda K, Sakaguchi K, Ohnishi H, Aoki Y, Ozeki M. | Comprehensive targeted next-generation sequeincing in ptients with slow-flow vascular malformations | J. Human Genet. | 2022 Sep 29. Online ahead of print | 2022 | 10.1038/s10038-022-01081-6 |
2257005 | 原著 | Orito Y, Otani N, Matsumoto Y, Fujimoto K, Oshima N, Maas BM, Caro L, Aliprantis AO, Cox KS, Tokumaru O, Kodama M, Kudo H, Imai H, Uemura N. | A Phase 1 Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody MK-1654 in Healthy Japanese Adults. | Clinical and translational science | 15(7) 1753-1763 | 2022 | |
2257006 | 総説 | Otani N, Ouchi M, Misawa K, Hisatome I, Anzai N. |
Hypouricemia and Urate Transporters | Biomedicines | Biomedicines 2022, 10, 652. https://doi.org/10.3390/ biomedicines10030652 |
2022 | |
2257007 | 原著 | Hirayama K, Kuranari M, Wakuda H, Otani N, Imai H, Uemura N. | Scientific misconduct in sponsored clinical trials in Japan – Published cases are the “tip of the iceberg” | Translational and Regulatory Sciences | 4(2): 30-36 | 2022 | |
2257008 | 原著 | Umegawa Y, Yamamoto T, Dixit M, Funahashi K, Seo S, Nakagawa Y, Suzuki T, Matsuoka S, Tsuchikawa H, Hanashima S, Oishi T, Matsumori N, Shinoda W, Murata M. | Amphotericin B assembles into seven-molecule ion channels: An NMR and molecular dynamics study | Sci Adv | 2022 Jun 17;8(24):eabo2658. | 2022 | 10.1126/sciadv.abo2658. |
2257009 | 原著 | Sugiyama S, Matsuoka D, Hara T, Sonoyama M, Matsuoka S, Murata M. | Experimental and theoretical investigations into the mechanism of interactions between membrane-bound fatty acids and their binding protein: A model system to investigate the behavior of lipid acyl chains in contact with proteins | Chem Phys Lipids | 2022 Sep;247:105227. | 2022 | 10.1016/j.chemphyslip.2022.105227 |
2257010 | 原著 | Nishida M, Terabayashi T, Matsuoka S, Okuma T, Adachi S, Tomo T, Kawano M, Tanaka K, Tsumura H, Anai H, Ishizaki T, Nishida Y, Hanada K. | Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition | Commun Biol | 2022 Sep 16;5(1):982. | 2022 | 10.1038/s42003-022-03920-w. |
2257011 | 原著 | Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Sinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. | A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study). | BMC Med. | 2022 Sep 27;20(1):342. | 2022 | 10.1186/s12916-022-02518-7. |
2257012 | 原著 | Nakamura K, Fujimoto K, Hasegawa C, Aoki I, Yoshitsugu H, Ugai H, Yatsuzuka N, Tanaka Y, Furihata K, Maas BM, Wickremasingha PK, Duncan KE, Iwamoto M, Stoch SA, Uemura N. | A phase I, randomized, placebo-controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID-19. | Clin Transl Sci. | 2022 Nov;15(11):2697-2708. Epub 2022 Sep 23. |
2022 | 10.1111/cts.13395. |
2257013 | 原著 | Imai H, Hashimoto S, Ninomiya R, Luo J, Wakuda H, Otani N, Inoue G, Amagishi H, Uemura N. | Pharmacokinetics of lanoconazole in human skin after repeated topical application. | J Dermatol. | 2022 Nov;49(11):1118-1123. Epub 2022 Jul 10. |
2022 | 10.1111/1346-8138.16515. |
2257014 | 原著 | Nakagama Y, Rodriguez-Funes MV, Dominguez R, Candray-Medina KS, Uemura N, Tshibangu-Kabamba E, Nitahara Y, Kaku N, Kaneko A, Kido Y. | Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America. | Clin Microbiol Infect. | 2022 Nov;28(11):1508-1510. Epub 2022 Jun 28. |
2022 | 10.1016/j.cmi.2022.06.020. |
2257015 | 原著 | Orito Y, Otani N, Matsumoto Y, Fujimoto K, Oshima N, Maas BM, Caro L, Aliprantis AO, Cox KS, Tokumaru O, Kodama M, Kudo H, Imai H, Uemura N. | A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults. | Clin Transl Sci. | 2022 Jul;15(7):1753-1763. Epub 2022 May 17. |
2022 | 10.1111/cts.13290. |
2257016 | 原著 | Kinoshita T, Shinoda M, Nishizaki Y, Shiraki K, Hirai Y, Kichikawa Y, Tsushima K, Shinkai M, Komura N, Yoshida K, Kido Y, Kakeya H, Uemura N, Kadota J. | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) | BMC Med | 20(1)478 | 2022 | 10.1186/s12916-022-02695-5 |